John W. Holaday, Ph.D. is Founder and CEO of DisposeRx, Inc. (http://www.dispose-rx.com). Previously was co-founder of QRxPharma Limited (QRX-ASX), Medicis Pharmaceuticals (MRX-NYSE) and EntreMed (ENMD-NASDAQ) holding various positions as CEO and Chairman. Dr. Holaday serves on the Board of Directors of Pixspan, CytImmune Sciences and Accelovance. He obtained his BS and MS from the University of Alabama, and his PhD from the University of California, San Francisco School of Medicine. He is a Fellow in the American College of Neuropsychopharmacology (FACNP) and a Fellow in Critical Care Medicine (FCCM). Dr. Holaday has served as officer and director of many professional and philanthropic organizations and societies. Prior experience included service at the Walter Reed Army Institute of Research as a Captain, US Army, and later as head of the Neuropharmacology Dept. Dr. Holaday was Adj. Professor of Anesthesiology and Critical Care Medicine at the Johns Hopkins University, and serves as Adj. Professor of Psychiatry at the Uniformed Services University of the Health Sciences. Dr. Holaday has received numerous honors and awards, including being named to the E&Y Entrepreneur of the Year 2006 Hall of Fame. He holds over 90 patents and has published over 230 scientific articles and five books.
Check out the incredible speaker line-up to see who will be joining John.